GlassScriptPhysician profile
Francessca L Glynn
NPI 1063474690
$7,839.77
in general payments reported to CMS, 2019-2025
61 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,281 · 2020: $941 · 2021: $1,395 · 2022: $2,024 · 2023: $1,440 · 2024: $362 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,198.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $902.07 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $638.29 | 2019-2023 | Breztri, Bevespi Aerosphere, Fasenra |
| Novo Nordisk INC | $636.02 | 2019-2023 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $491.29 | 2019-2023 | Evenity, Prolia, Otezla |
| Lilly USA, LLC | $490.12 | 2019-2025 | Emgality, Trulicity, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $368.17 | 2019-2023 | Jardiance |
| Pfizer INC. | $303.66 | 2019-2025 | |
| Glaxosmithkline, LLC. | $295.74 | 2019-2023 | Trelegy Ellipta |
| Abbott Laboratories | $272.90 | 2021-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $231.29 | 2019-2023 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
| Allergan, INC. | $215.72 | 2019-2020 | |
| Exact Sciences Corporation | $209.92 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $135.60 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $127.14 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.99 | 2021-2023 |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francessca Glynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.